Semi-Annual Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7330327

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,695,000,000 JPY
216,000,000 JPY
Interest and dividends received
501,000,000 JPY
473,000,000 JPY
Interest paid
-66,000,000 JPY
-66,000,000 JPY
Income taxes paid
-2,975,000,000 JPY
-2,065,000,000 JPY
Net cash provided by (used in) operating activities
1,549,000,000 JPY
2,008,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-5,778,000,000 JPY
-6,330,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
100,000,000 JPY
Purchase of investment securities
0 JPY
-100,000,000 JPY
Other, net
-509,000,000 JPY
-251,000,000 JPY
Net cash provided by (used in) investing activities
-3,187,000,000 JPY
-6,275,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-200,000,000 JPY
-200,000,000 JPY
Dividends paid
-3,013,000,000 JPY
-3,015,000,000 JPY
Net cash provided by (used in) financing activities
-3,347,000,000 JPY
-3,363,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
87,000,000 JPY
241,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-4,897,000,000 JPY
-7,388,000,000 JPY
Cash and cash equivalents
13,886,000,000 JPY
18,816,000,000 JPY
26,289,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.